PFR | Isoform Accession | Modifications | Length | Confidence |
---|---|---|---|---|
163034 | Q5VTE0 | 37 | ![]() |
|
163035 | Q5VTE0 | 36 | ![]() |
|
163036 | Q5VTE0 | 40 | ![]() |
|
163037 | Q5VTE0 | 30 | ![]() |
|
163038 | Q5VTE0 | 35 | ![]() |
|
163039 | Q5VTE0 | 5-L-glutamyl glycerylphosphorylethanolamine@301 | 41 | ![]() |
163040 | Q5VTE0 | 47 | ![]() |
|
163041 | Q5VTE0 | 28 | ![]() |
|
163042 | Q5VTE0 | 27 | ![]() |
|
163043 | Q5VTE0 | 30 | ![]() |
|
163044 | Q5VTE0 | 22 | ![]() |
|
163045 | Q5VTE0 | 32 | ![]() |
|
163046 | Q5VTE0 | 34 | ![]() |
|
163047 | Q5VTE0 | 40 | ![]() |
|
163048 | Q5VTE0 | 20 | ![]() |
|
163049 | Q5VTE0 | 5-L-glutamyl glycerylphosphorylethanolamine@301 | 31 | ![]() |
163050 | Q5VTE0 | 5-L-glutamyl glycerylphosphorylethanolamine@301 | 46 | ![]() |
163051 | Q5VTE0 | 36 | ![]() |
|
163052 | Q5VTE0 | 40 | ![]() |
|
163053 | Q5VTE0 | 27 | ![]() |